See our Clinical Trial
or send us an e-mail directly: email@example.com
Your local healthcare professional remains your best source of information. He or she is familiar with your specific type of spinal cord lesion and can inform you about possibilities with G-Therapeutics. We are associated with clinical studies that are conducted by internationally renowned clinicians. Find our trial through the link below
Our current focus is to treat paraplegic patients with an incomplete spinal cord injury (ASIA-C and -D). The stimulation electrode will be inserted in the epidural space of the spinal cord at the lumbar level L1-L2. Therefore, spinal cord lesion should be at max T10 or above. In the future we aim to also treat tetraplegia and more severe spinal cord injuries (ASIA-A, B). Promising advancements have been made in pre-clinical research. Please contact us below for more information.